ArticleFrontiers in surgery2025
ERAS protocol vs. conventional care in elective laparoscopic colorectal cancer surgery in Hatyai Hospital.
Article in Frontiers in surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Enhanced recovery after surgery (ERAS) programs and laparoscopic techniques independently reduce hospital stays and postoperative complications in patients with colorectal cancer. However, evidence regarding whether the combination of ERAS protocols with laparoscopic surgery further improves postoperative outcomes remains limited. Objective: The aim of the study was to compare the postoperative hospital stay (POHS) and perioperative outcomes between patients undergoing elective laparoscopic colorectal cancer surgery under the ERAS protocol and conventional care. Methods: This ambispective cohort study included patients who underwent elective laparoscopic colorectal surgery for colorectal adenocarcinoma at Hatyai Hospital between June 2019 and May 2023. Patients were divided into a conventional group and an ERAS group. The primary outcome was POHS. Secondary outcomes included postoperative complications and 30-day readmission. Results: A total of 140 patients were included (70 ERAS, 70 conventional). Baseline characteristics were similar between groups, though the ERAS group had more preoperative chemoradiotherapy (CCRT) (52.9% vs. 39.4%; Conclusion: ERAS implementation in elective laparoscopic colorectal cancer surgery significantly reduces hospital stay without increasing complication or readmission rates. These findings support the safety and effectiveness of ERAS in a regional Thai hospital setting and advocate for broader protocol adoption.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.